Tristel (GB:TSTL) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Tristel PLC announces the submission of a 510(k) Premarket Notification to the FDA for its unique high-level disinfectant, Tristel OPH, designed for ophthalmic devices. If cleared, it promises to revolutionize infection prevention in North American ophthalmic procedures, offering a fast and effective alternative to current low-level disinfectants. CEO Matt Sassone is optimistic about receiving FDA clearance by end of 2024 and is preparing for distribution agreements in the US.
For further insights into GB:TSTL stock, check out TipRanks’ Stock Analysis page.
